PRE-OPERATIVE URINARY PROSTATE CANCER GENE 3 (PCA3) IS PREDICTING PATHOLOGICALLY CONFIRMED SMALL VOLUME AND INSIGNIFICANT PROSTATE CANCER

被引：0
|
作者：
Auprich, Marco
Ward, John F.
Babaian, Richard
Pummer, Karl
Augustin, Herbert
Luger, Ferdinand
Gutschi, Stefan
Huland, Hartwig
Haese, Alexander
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.257
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
187
引用
收藏
页码：E77 / E77
页数：1
相关论文
共 50 条
  • [21] COMPARISON OF PROSTATE HEALTH INDEX, URINARY PCA3 ASSAY AND % FREE PSA IN PREDICTING PROSTATE CANCER AT FIRST BIOPSY
    De Luca, Stefano
    Parziale, Adele
    Caccia, Paolo
    Cavallini, Andrea
    Faraone, Nicola
    Giargia, Ernesto
    Pasquale, Massimo
    Squeo, Maria Sara
    Milillo, Angela
    Randone, Donato Franco
    ANTICANCER RESEARCH, 2013, 33 (05) : 2277 - 2278
  • [22] PROSTATE BIOPSY: PATHOLOGICAL PATTERNS IN MEN WITH PROSTATE CANCER GENE 3 (PCA3) SCORE FLUCTUATIONS
    De Luca, Stefano
    Passera, Roberto
    Bollito, Enrico
    Cappia, Susanna
    Amparore, Daniele
    Cattaneo, Giovanni
    Manfredi, Matteo
    Mele, Fabrizio
    Bertolo, Riccardo
    Porpiglia, Francesco
    ANTICANCER RESEARCH, 2015, 35 (06) : 3723 - 3723
  • [23] Predicting prostate cancer risk through incorporation of a molecular biomarker: PCA3
    Ankerst, Donna Pauler
    Groskopf, Jack
    Day, John R.
    Blase, Amy
    Rittenhouse, Harry
    Pollock, Brad H.
    Tangen, Cathy
    Parekh, Dipen
    Leach, Robin
    Thompson, Ian
    CANCER BIOMARKERS, 2008, 4 (03) : 163 - 164
  • [24] The Novel Prostate Cancer Antigen 3 (PCA3) Biomarker
    Bourdoumis, Andreas
    Papatsoris, Athanasios G.
    Chrisofos, Michael
    Efstathiou, Eleni
    Skolarikos, Andreas
    Deliveliotis, Charalambos
    INTERNATIONAL BRAZ J UROL, 2010, 36 (06): : 665 - 668
  • [25] Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
    Wei, John T.
    Feng, Ziding
    Partin, Alan W.
    Brown, Elissa
    Thompson, Ian
    Sokoll, Lori
    Chan, Daniel W.
    Lotan, Yair
    Kibel, Adam S.
    Busby, J. Erik
    Bidair, Mohamed
    Lin, Daniel W.
    Taneja, Samir S.
    Viterbo, Rosalia
    Joon, Aron Y.
    Dahlgren, Jackie
    Kagan, Jacob
    Srivastava, Sudhir
    Sanda, Martin G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4066 - U274
  • [26] Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
    Ferro, Matteo
    Bruzzese, Dario
    Perdona, Sisto
    Mazzarella, Claudia
    Marino, Ada
    Sorrentino, Alessandra
    Di Carlo, Angelina
    Autorino, Riccardo
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    Altieri, Vincenzo
    Mariano, Angela
    Macchia, Vincenzo
    Terracciano, Daniela
    CLINICA CHIMICA ACTA, 2012, 413 (15-16) : 1274 - 1278
  • [27] PREDICTING PROSTATE BIOPSY OUTCOME: PROSTATE HEALTH INDEX (PHI) AND PROSTATE CANCER ANTIGEN 3 (PCA3) ARE USEFUL BIOMARKERS
    Ferro, Matteo
    Montanaro, Vittorino
    Marsicano, Mariano
    Capece, Marco
    Terracciano, Daniela
    Sorrentino, Alessandra
    Marino, Ada
    Quarto, Giuseppe
    De Domenico, Renato
    Sorrentino, Domenico
    Altieri, Vincenzo
    Perdona, Sisto
    ANTICANCER RESEARCH, 2012, 32 (05) : 1940 - 1941
  • [28] PCA3 Test as an Adjunct in Diagnosis of Prostate Cancer
    Yutkin, V
    Al-Zahrani, A.
    Williams, A.
    Hidas, G.
    Martines, C.
    Izawa, J.
    Pode, D.
    Chin, J.
    UROLOGY, 2012, 80 (03) : S140 - S140
  • [29] PCA3 regulates nucleoplasmic lamina in prostate cancer
    Ito, Saya
    Ueda, Takashi
    Yokoyama, Atsushi
    Hongo, Fumiya
    Ukimura, Osamu
    CANCER SCIENCE, 2021, 112 : 644 - 644
  • [30] The use of PCA3 mRNA in the diagnosis of prostate cancer
    Crawley, S.
    Hennessey, D. B.
    Tyson, M.
    Subin, F.
    Pahuja, A.
    Wilson, R.
    Ryan, M. F.
    BJU INTERNATIONAL, 2014, 114 : 18 - 18
12345